[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.146.179.146. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Views 549
Citations 0
Correction
December 2015

Error in Text

JAMA Neurol. 2015;72(12):1537. doi:10.1001/jamaneurol.2015.4174

In the Editorial titled “Equivalence of Glatiramer Acetate Generics With Branded Glatiramer Acetate in Efficacy and Cost for the Treatment of Multiple Sclerosis,” published online October 12, 2015, in JAMA Neurology,1 there was a reference error in the second sentence of the second paragraph. The second sentence should read as follows: “Arnon and colleagues2,3 assessed the effects of synthetic polypeptides on the MS model of experimental autoimmune encephalomyelitis.” This article was corrected online.

References
1.
Bourdette  D, Hartung  D.  Equivalence of glatiramer acetate generics with branded glatiramer acetate in efficacy and cost for the treatment of multiple sclerosis. JAMA Neurol. 2015;1-3. doi:10.1001/jamaneurol.2015.2605.
PubMed
×